皮肤瘢痕疙瘩、肥厚性瘢痕及纤维化与术后增生性玻璃体视网膜病变风险的关联
基于TriNetX电子健康记录数据库的回顾性人群队列研究,纳入2003年1月1日至2023年3月1日期间接受视网膜脱离修复术的成人患者,分析皮肤瘢痕疙瘩、肥厚性瘢痕及纤维化(KHF)与术后增生性玻璃体视网膜病变(PVR)风险的关联。在经倾向评分匹配的玻璃体切割术(伴或不伴巩膜扣带)患者中,KHF队列180天内PVR诊断率为10.1%,非KHF队列为3.4%(P<0.001,OR 3.2,95%CI 2.13-4.71)。结论认为皮肤KHF病史可能是视网膜脱离修复术后PVR的危险因素。
要点
- 在经倾向评分匹配的玻璃体切割术(伴或不伴巩膜扣带)患者中,KHF队列180天内PVR诊断率为10.1%,非KHF队列为3.4%(P<0.001,OR 3.2,95%CI 2.13-4.71)。
- 在经倾向评分匹配的玻璃体切割术(伴或不伴巩膜扣带)患者中,KHF队列复杂视网膜脱离修复术(CPT 67113)比例为8.3%,非KHF队列为5.4%(P=0.008;OR 3.2;95%CI 1.13-2.25)。
- 纳入所有视网膜脱离修复类型时,KHF队列PVR诊断率仍显著高于非KHF队列(9.0% vs 4.2%,P<0.01;OR 2.28;95%CI 1.64-3.16)。
核心结论
- 皮肤KHF病史可能是视网膜脱离修复术后PVR的危险因素。
研究设计与样本
- 回顾性、基于人群的队列研究。
- 纳入2003年1月1日至2023年3月1日期间接受初次视网膜脱离修复术(玻璃体切割术伴或不伴巩膜扣带,CPT 67108;充气性视网膜固定术,CPT 67110;初次巩膜扣带术,CPT 67107)的18岁及以上患者。
- 使用TriNetX去标识化电子健康记录数据库,通过ICD-10编码L91.0(肥厚性瘢痕)和L90.5(皮肤瘢痕状况及纤维化)查询患者,排除增殖性糖尿病视网膜病变(ICD-10 H10.35/H11.35)患者。
- 采用描述性统计(Z检验)和倾向评分匹配(PSM)对年龄、性别和种族进行匹配。
主要发现
- 在CPT 67108患者中,经PSM后KHF队列和非KHF队列各1061例,平均(标准差)年龄为60.7(15.2)岁。
- 在CPT 67108患者中,180天内KHF队列10.1%和非KHF队列3.4%的患者诊断为PVR(H35.2)(P<0.001,OR 3.2;95%CI 2.13-4.71)。
- 在CPT 67108患者中,KHF队列8.3%和非KHF队列5.4%的患者接受了复杂视网膜脱离修复术(CPT 67113)(P=0.008;OR 3.2;95%CI 1.13-2.25)。
- 纳入所有视网膜脱离修复类型(CPT 67108、67110、67107)时,KHF队列PVR诊断率为9.0%,非KHF队列为4.2%(P<0.01;OR 2.28;95%CI 1.64-3.16)。
关键数值与推荐
- 在CPT 67108患者中,180天内PVR(H35.2)诊断率:KHF队列10.1% vs 非KHF队列3.4%(P<0.001,OR 3.2;95%CI 2.13-4.71)。
- 在CPT 67108患者中,180天内复杂视网膜脱离修复术(CPT 67113)比例:KHF队列8.3% vs 非KHF队列5.4%(P=0.008;OR 3.2;95%CI 1.13-2.25)。
- 纳入所有视网膜脱离修复类型时,PVR诊断率:KHF队列9.0% vs 非KHF队列4.2%(P<0.01;OR 2.28;95%CI 1.64-3.16)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess an association between cutaneous keloids, hypertrophic scarring, and fibrosis (KHF) and risk of postoperative proliferative vitreoretinopathy (PVR) after rhegmatogenous retinal detachment (RRD) repair. DESIGN: Retrospective, population-based cohort study. PARTICIPANTS: Patients aged ≥ 18 years who underwent initial retinal detachment (RD) repair with pars plana vitrectomy with or without scleral buckle (SB) (Current Procedural Terminology [CPT] 67108), pneumatic retinopexy (67110), and primary SB (67107) from January 1, 2003, to March 1, 2023. METHODS: A de-identified electronic health record database through TriNetX, a global health research network, was used to analyze patients. Patients were queried for International Classification of Diseases, 10th Revision (ICD-10) codes L91.0 (hypertrophic scar) and L90.5 (scar conditions and fibrosis of skin). Frequency of subsequent diagnosis of PVR (H35.2) and CPT codes for secondary surgery including complex RD repair (67113) were determined. Patients with proliferative diabetic retinopathy (PDR) (ICD-10 H10.35/H11.35) were excluded. Descriptive statistics (Z-test) and propensity score matching (PSM) were used to match for age, sex, and race. MAIN OUTCOME MEASURES: Prevalence of H35.2 and CPT 67113 within 180 days after RRD repair in the KHF cohort versus the non-KHF cohort. RESULTS: Among patients with CPT 67108, 1061 in each cohort (KHF and non-KHF) were analyzed after PSM. The mean (standard deviation) age was 60.7 (15.2) years. Within 180 days, 10.1% of patients in the KHF cohort and 3.4% in the non-KHF cohort had a diagnosis of PVR (H35.2) (P < 0.001, odds ratio [OR], 3.2; 95% confidence interval [CI], 2.13-4.71). A total of 8.3% of patients in the KHF cohort and 5.4% of patients in the non-KHF cohort underwent complex RD repair (CPT 67113) (P = 0.008; OR, 3.2; 95% CI, 1.13-2.25). When including all RD repair types (CPT 67108, 67110, 67107), the rate of PVR diagnosis was still significantly greater in the KHF cohort than in the non-KHF cohort (9.0% vs 4.2%, P < 0.01; OR, 2.28; 95% CI, 1.64-3.16). CONCLUSIONS: A dermatologic history of KHF may be a risk factor for PVR after RD repair. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
引用
- Mammo DA, Wai K, Rahimy E, et al. Association of Cutaneous Keloids, Hypertrophic Scarring, and Fibrosis with Risk of Postoperative Proliferative Vitreoretinopathy. Ophthalmology. 2024. PMID: 38296203. doi:10.1016/j.ophtha.2024.01.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。